138 related articles for article (PubMed ID: 2366224)
1. Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs.
Moore AS; Cardona A; Shapiro W; Madewell BR
J Vet Intern Med; 1990; 4(3):148-52. PubMed ID: 2366224
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
Upton ML; Tangner CH; Payton ME
J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
[TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
Henry CJ; Flesner BK; Bechtel SA; Bryan JN; Tate DJ; Selting KA; Lattimer JC; Bryan ME; Grubb L; Hausheer F
J Vet Intern Med; 2018 Jan; 32(1):370-376. PubMed ID: 29080252
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs.
Shapiro W; Kitchell BE; Fossum TW; Couto CG; Theilen G
J Am Vet Med Assoc; 1988 Dec; 193(12):1530-3. PubMed ID: 3215812
[TBL] [Abstract][Full Text] [Related]
8. Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma.
Stone EA; Withrow SJ; Page RL; Schwarz PD; Wheeler SL; Seim HB
Vet Surg; 1988; 17(3):147-53. PubMed ID: 3238887
[TBL] [Abstract][Full Text] [Related]
9. Total cystectomy for treatment of transitional cell carcinoma of the urethra and bladder trigone in a dog.
Boston S; Singh A
Vet Surg; 2014 Mar; 43(3):294-300. PubMed ID: 24433358
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.
Arnold EJ; Childress MO; Fourez LM; Tan KM; Stewart JC; Bonney PL; Knapp DW
J Vet Intern Med; 2011; 25(6):1385-90. PubMed ID: 22092632
[TBL] [Abstract][Full Text] [Related]
11. Results of biopsy via transurethral cystoscopy and cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008).
Childress MO; Adams LG; Ramos-Vara JA; Freeman LJ; He S; Constable PD; Knapp DW
J Am Vet Med Assoc; 2011 Aug; 239(3):350-6. PubMed ID: 21801049
[TBL] [Abstract][Full Text] [Related]
12. What is your diagnosis? Irregular surface of the bladder and urethra, and circumferential filling defect at the neck of the bladder and proximal portion of the urethra.
Eslinger LL; Byers MA; Kantrowitz BM
J Am Vet Med Assoc; 1995 Jan; 206(1):31-2. PubMed ID: 7744658
[No Abstract] [Full Text] [Related]
13. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T
J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623
[TBL] [Abstract][Full Text] [Related]
14. Needle-tract implantation following us-guided fine-needle aspiration biopsy of transitional cell carcinoma of the bladder, urethra, and prostate.
Nyland TG; Wallack ST; Wisner ER
Vet Radiol Ultrasound; 2002; 43(1):50-3. PubMed ID: 11866046
[TBL] [Abstract][Full Text] [Related]
15. Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
Mohammed SI; Craig BA; Mutsaers AJ; Glickman NW; Snyder PW; deGortari AE; Schlittler DL; Coffman KT; Bonney PL; Knapp DW
Mol Cancer Ther; 2003 Feb; 2(2):183-8. PubMed ID: 12589035
[TBL] [Abstract][Full Text] [Related]
16. Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
Robat C; Burton J; Thamm D; Vail D
J Small Anim Pract; 2013 Feb; 54(2):67-74. PubMed ID: 23286739
[TBL] [Abstract][Full Text] [Related]
17. Radiographic appearance of pulmonary metastases from transitional cell carcinoma of the bladder and urethra of the dog.
Walter PA; Haynes JS; Feeney DA; Johnston GR
J Am Vet Med Assoc; 1984 Aug; 185(4):411-8. PubMed ID: 6469838
[TBL] [Abstract][Full Text] [Related]
18. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study.
Poirier VJ; Forrest LJ; Adams WM; Vail DM
J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer.
Knapp DW; Glickman NW; Widmer WR; DeNicola DB; Adams LG; Kuczek T; Bonney PL; DeGortari AE; Han C; Glickman LT
Cancer Chemother Pharmacol; 2000; 46(3):221-6. PubMed ID: 11021739
[TBL] [Abstract][Full Text] [Related]
20. Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases.
Gustafson TL; Biller B
J Am Anim Hosp Assoc; 2019; 55(5):243-248. PubMed ID: 31433219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
